Enforcement, Litigation, and Compliance Conference
For the Drug, Device, Food and Tobacco Industries
December 12–13, 2018 | Washington, DC
The Changing OTC Drug Regulatory Landscape
December 6, 2018 | Washington, DC
For the New to Food and Drug Law Group only
Drug Quality and Security Act Conference
December 4, 2018 | Washington, DC
No Longer Business as Usual: FDA Exceptionalism, Commercial Speech, and the First Amendment (Open Access) GalleryNo Longer Business as Usual: FDA Exceptionalism, Commercial Speech, and the First Amendment (Open Access)
Archived Publication, Drugs, Medical Devices, Biologics, Food and Drug Law Journal, Food, Dietary Supplements, Cosmetics, Publications, Tobacco Products, Volume 73.4
No Longer Business as Usual: FDA Exceptionalism, Commercial Speech, and the First Amendment (Open Access)
Food and Drug Law Journal | Volume 73 | Number 4
The Evolving Regulatory Landscape for Clinical Trials in India
Food and Drug Law Journal | Volume 73 | Number 4
The Responsible Corporate Officer Doctrine: Protections are Needed Despite DOJ’s Cautious Approach GalleryThe Responsible Corporate Officer Doctrine: Protections are Needed Despite DOJ’s Cautious Approach
Archived Publication, Drugs, Medical Devices, Biologics, Food, Dietary Supplements, Cosmetics, Interest, Publications, Tobacco Products, Update December 2018/January 2019, Update Magazine
The Responsible Corporate Officer Doctrine: Protections are Needed Despite DOJ’s Cautious Approach
Update Magazine | December 2018/January 2019
Un-“Stacking” Class Actions
Update Magazine | December 2018/January 2019
A Storm Is Brewing: What Happened to the Generic Pharmaceutical Anti-Trust Price Fixing Criminal Investigation? GalleryA Storm Is Brewing: What Happened to the Generic Pharmaceutical Anti-Trust Price Fixing Criminal Investigation?
Archived Publication, Drugs, Medical Devices, Biologics, Interest, Publications, Update December 2018/January 2019, Update Magazine
A Storm Is Brewing: What Happened to the Generic Pharmaceutical Anti-Trust Price Fixing Criminal Investigation?
Update Magazine | December 2018/January 2019
Gene Therapy – FDA Takes Steps Toward Clarifying Scope of Orphan Drug Exclusivity GalleryGene Therapy – FDA Takes Steps Toward Clarifying Scope of Orphan Drug Exclusivity
Archived Publication, Drugs, Medical Devices, Biologics, Interest, Publications, Update December 2018/January 2019, Update Magazine
Gene Therapy – FDA Takes Steps Toward Clarifying Scope of Orphan Drug Exclusivity
Update Magazine | December 2018/January 2019
FDA’s New Pilot Program Encouraging Innovation
Update Magazine | December 2018/January 2019
